Back
Panbela Therapeutics Stock Price Chart
Sponsored
PBLA
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Sell
24
PBLA
Panbela Therapeutics
Last Price:
0.43
Seasonality Move:
-3.76%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing slight selling pressure.
Panbela Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.44 | Sell |
20-day SMA: | 0.5 | Sell |
50-day SMA: | 0.73 | Sell |
200-day SMA: | 14.89 | Sell |
8-day EMA: | 0.45 | Sell |
20-day EMA: | 0.52 | Sell |
50-day EMA: | 1.61 | Sell |
200-day EMA: | 752.15 | Sell |
Panbela Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 34.57 | Sell |
Chaikin Money Flow: | -15255 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 0.61) | Sell |
Bollinger Bands (100): | (-1.7 - 11.88) | Sell |
Panbela Therapeutics Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Panbela Therapeutics Stock
Is Panbela Therapeutics Stock a Buy?
- Panbela Therapeutics share price is 0.44 while PBLA 8-day simple moving average is 0.44, which is a Sell signal.
- The stock price of PBLA is 0.44 while Panbela Therapeutics 20-day SMA is 0.50, which makes it a Sell.
- Panbela Therapeutics 50-day simple moving average is 0.73 while PBLA share price is 0.44, making it a Sell technically.
- PBLA stock price is 0.44 and Panbela Therapeutics 200-day simple moving average is 14.89, creating a Sell signal.
PBLA Technical Analysis vs Fundamental Analysis
Sell
24
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy or a Sell?
-
Panbela Therapeutics stock is rated a Sell
The current Panbela Therapeutics [PBLA] share price is $0.44. The Score for PBLA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Panbela Therapeutics Stock Info
Market Cap:
2.11M
Price in USD:
0.44
Share Volume:
70.41K
Panbela Therapeutics 52-Week Range
52-Week High:
320.16
52-Week Low:
0.35
Sell
24
Panbela Therapeutics (PBLA)
is a Sell
Panbela Therapeutics Share Price Forecast
-
What is the Panbela Therapeutics stock price today?
The Panbela Therapeutics stock price is 0.44 USD today. -
Will PBLA stock go up or go down?
Panbela Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Panbela Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Panbela Therapeutics is overvalued.
Is Panbela Therapeutics Stock a Buy?
- Panbela Therapeutics share price is 0.44 while PBLA 8-day exponential moving average is 0.45, which is a Sell signal.
- The stock price of PBLA is 0.44 while Panbela Therapeutics 20-day EMA is 0.52, which makes it a Sell.
- Panbela Therapeutics 50-day exponential moving average is 1.61 while PBLA share price is 0.44, making it a Sell technically.
- PBLA stock price is 0.44 and Panbela Therapeutics 200-day simple moving average is 752.15, creating a Sell signal.
Fundamental Analysis of Panbela Therapeutics
Is Panbela Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $39.91 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,223.30 per share, and a decrease next year of $0.36 per share.
Technical Analysis of Panbela Therapeutics
Should I short Panbela Therapeutics stock?
- PBLA Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Panbela Therapeutics is a Sell
- Panbela Therapeutics Relative Strength Index (RSI) is 34.57, which suggest Panbela Therapeutics is oversold
- The Bollinger Bands (25) for Panbela Therapeutics is (0.45 - 0.61), which suggest Panbela Therapeutics is a Sell
- The Bollinger Bands (100) for Panbela Therapeutics is (-1.7 - 11.88), which suggest Panbela Therapeutics is a Sell
* Panbela Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.